journal article·2025-12-24Open access

Photodynamic Antibacterial Nanofibers with Tunable Pro- and Antioxidant Activity via N,S-Doped Carbon Quantum Dots for Corneal Tissue Engineering

Roksana Kurpanik, Anna Ścisłowska-Czarnecka, Zofia Kucia, Agnieszka Lechowska-Liszka, Nikola Lenar, Agnieszka Różycka, Marcin Sarewicz, Grzegorz Szewczyk, Ewa Stodolak-Zych

ACS Applied Materials & Interfaces· Volume 17· Issue 51

Abstract

High Resolution Image Download MS PowerPoint Slide Antibiotic resistance poses a critical challenge in ocular medicine, where treatments must combine antibacterial potency with tissue compatibility. Electrospun core–shell nanofibers offer an attractive solution for ocular applications as they provide a biomimetic extracellular matrix structure with controlled drug release and surface functionality. In this work, polycaprolactone (PCL) was used as the mechanically robust, biodegradable core, while polyvinylpyrrolidone (PVP) formed a hydrophilic shell to enhance wettability and ocular compatibility. The nanofibers were further functionalized with N,S-doped carbon quantum dots, exhibiting light-switchable redox behavior. Compositional and spectroscopic analyses revealed that N,S-doped CQDs possessed a significantly narrowed bandgap (3.14 eV) relative to cysteine- and tryptophan-derived CQDs, attributable to heteroatom-induced defect states and the formation of π–π conjugated domains, confirmed by X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FT-IR). XPS measurements showed valence band energies suitable for superoxide generation under illumination, consistent with the reported redox potentials. As a result, illuminated nanofibers produced reactive oxygen species (ROS), reducing Escherichia coli and Staphylococcus aureus populations by 90% and 80%, respectively. In the dark, the same CQDs exhibited up to 90% radical-scavenging activity, increasing BJ human fibroblast viability by 35%. Additional mechanistic evidence indicated that light enhances the adhesion of CQDs to bacterial membranes, further promoting ROS-mediated inactivation. With a high quantum yield of 50% and strong blue fluorescence (λ em = 445 nm, λ ex = 380 nm), the CQDs also offer imaging and diagnostic potential. Together, these findings position N,S-doped CQDs-modified core–shell nanofibers as a biologically adaptive platform capable of photodynamic antibacterial action while supporting cytoprotection and tissue regeneration─an innovative approach for combating antibiotic-resistant ocular infections.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Nanoplatforms for cancer theranostics · Corneal Surgery and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomaterials and Composites, Faculty of Materials Science and Ceramics

AGH University of Krakow

Department of Applied Cosmetology

University of Physical Education

Department of Silicate Chemistry and Macromolecular Compounds, Faculty of Materials Science and Ceramics

Department of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics

Department of Building Materials Technology, Faculty of Materials Science and Ceramics

Department of Molecular Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology

Jagiellonian University

Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology

Funding

Akademia G?rniczo-Hutnicza im. Stanislawa Staszica · Research University program at the AGH University of Krakow

References (70)

Show source-provided references
1. 10.1007/s00253-024-13009-510.1007/s00253-024-13009-5 ↗
2. 10.1038/s41433-024-03323-710.1038/s41433-024-03323-7 ↗
3. 10.1016/j.jpha.2025.10125010.1016/j.jpha.2025.101250 ↗
4. 10.1016/j.jsamd.2025.10093310.1016/j.jsamd.2025.100933 ↗
5. 10.1088/1748-605X/ad6ac510.1088/1748-605X/ad6ac5 ↗
6. 10.1038/s41598-024-61567-510.1038/s41598-024-61567-5 ↗
7. 10.1111/wrr.1312610.1111/wrr.13126 ↗
8. 10.1021/acsomega.3c0091410.1021/acsomega.3c00914 ↗
9. 10.1016/j.colsurfb.2020.11094910.1016/j.colsurfb.2020.110949 ↗
10. 10.1016/j.bbamem.2017.09.00810.1016/j.bbamem.2017.09.008 ↗
11. 10.1016/j.biomaterials.2013.06.04810.1016/j.biomaterials.2013.06.048 ↗
12. 10.1016/j.carbon.2021.07.05410.1016/j.carbon.2021.07.054 ↗
13. 10.1186/s12951-024-02479-410.1186/s12951-024-02479-4 ↗
14. 10.1021/acsomega.3c0179510.1021/acsomega.3c01795 ↗
15. 10.1016/j.nantod.2023.10183710.1016/j.nantod.2023.101837 ↗
16. 10.1016/j.cej.2021.12999010.1016/j.cej.2021.129990 ↗
17. 10.1016/j.jcis.2024.02.06310.1016/j.jcis.2024.02.063 ↗
18. 10.1016/j.jphotobiol.2023.11281810.1016/j.jphotobiol.2023.112818 ↗
19. 10.1038/s41598-023-36603-510.1038/s41598-023-36603-5 ↗
20. 10.3390/app1219973710.3390/app12199737 ↗
21. 10.1016/j.foodcont.2019.10696110.1016/j.foodcont.2019.106961 ↗
22. Lonza. ViaLight plus kit cell viability assay ; https://bioscience.lonza.com/lonza_bs/CH/en/Cell-analysis/p/000000000000186469/ViaLightTM-Plus-Cell-Proliferation-and-Cytotoxicity-BioAssay-Kit%2C-500-Test.
23. Lonza. ToxiLight TM bioassay kit ; https://bioscience.Lonza.com/lonza_bs/ch/en/cell-analysis/p/000000000000186486/ToxiLightTM-Non-Destructive-Cytotoxicity-BioAssay-Kit-With-Plates%2c-500-Test.
24. 10.1126/sciadv.abe310510.1126/sciadv.abe3105 ↗
25. 10.1007/s40090-015-0047-710.1007/s40090-015-0047-7 ↗
26. 10.1080/15685551.2015.113653010.1080/15685551.2015.1136530 ↗
27. 10.1021/jp992421c10.1021/jp992421c ↗
28. 10.1038/s41598-020-80450-710.1038/s41598-020-80450-7 ↗
29. 10.1021/acsomega.8b0275210.1021/acsomega.8b02752 ↗
30. 10.1039/D3RA07626A10.1039/D3RA07626A ↗
31. 10.1039/C6RA24971J10.1039/C6RA24971J ↗
32. Boukaoud A. · Sigma J. Eng. Nat. Sci. · 2019 · 37 · 1181
33. 10.1139/v56-23110.1139/v56-231 ↗
34. 10.1021/acs.jpcc.9b1173210.1021/acs.jpcc.9b11732 ↗
35. 10.3390/c603005810.3390/c6030058 ↗
36. 10.1016/j.jcis.2025.13729210.1016/j.jcis.2025.137292 ↗
37. 10.1080/0570492070182904310.1080/05704920701829043 ↗
38. 10.1016/j.foodchem.2020.12853910.1016/j.foodchem.2020.128539 ↗
39. 10.1016/S0371-1951(62)80164-710.1016/S0371-1951(62)80164-7 ↗
40. 10.1021/ED070PA25.510.1021/ED070PA25.5 ↗
41. 10.1016/j.apsusc.2022.15368110.1016/j.apsusc.2022.153681 ↗
42. 10.1002/sia.383110.1002/sia.3831 ↗
43. Naumkin A. V. · 2023
44. 10.1002/(SICI)1096-9918(199908)28:1<101::AID-SIA627>3.0.CO;2-010.1002/(SICI)1096-9918(199908)28:1<101::AID-SIA627>3.0.CO;2-0 ↗
45. 10.1021/acsnano.3c1079210.1021/acsnano.3c10792 ↗
46. 10.1039/C8NR00204E10.1039/C8NR00204E ↗
47. 10.1007/s10895-019-02431-y10.1007/s10895-019-02431-y ↗
48. 10.1109/TIA.2011.212743110.1109/TIA.2011.2127431 ↗
49. 10.1038/srep4392410.1038/srep43924 ↗
50. 10.1038/s41598-022-18632-810.1038/s41598-022-18632-8 ↗
51. 10.1007/s00396-013-2941-x10.1007/s00396-013-2941-x ↗
52. 10.1177/0967391121105330710.1177/09673911211053307 ↗
53. 10.1016/j.foodchem.2025.14398210.1016/j.foodchem.2025.143982 ↗
54. 10.1007/s11356-021-16156-810.1007/s11356-021-16156-8 ↗
55. 10.1016/j.compositesb.2021.10936410.1016/j.compositesb.2021.109364 ↗
56. 10.1021/acs.molpharmaceut.3c0039910.1021/acs.molpharmaceut.3c00399 ↗
57. 10.1016/j.dyepig.2022.11078410.1016/j.dyepig.2022.110784 ↗
58. 10.1021/acsomega.4c0974810.1021/acsomega.4c09748 ↗
59. 10.1016/j.cej.2019.12282710.1016/j.cej.2019.122827 ↗
60. 10.1007/s44251-023-00026-110.1007/s44251-023-00026-1 ↗
61. 10.1039/C8RA04664F10.1039/C8RA04664F ↗
62. 10.1021/acsami.1c0820010.1021/acsami.1c08200 ↗
63. 10.1016/j.msec.2021.11197110.1016/j.msec.2021.111971 ↗
64. 10.1038/s41467-022-30125-w10.1038/s41467-022-30125-w ↗
65. 10.1016/j.resmic.2010.11.00610.1016/j.resmic.2010.11.006 ↗
66. 10.1016/j.jcis.2020.06.12510.1016/j.jcis.2020.06.125 ↗
67. 10.1016/j.jtos.2023.04.01210.1016/j.jtos.2023.04.012 ↗
68. 10.1021/acsabm.0c0085410.1021/acsabm.0c00854 ↗
69. 10.1007/s10856-014-5199-z10.1007/s10856-014-5199-z ↗
70. 10.1088/1758-5090/abb74410.1088/1758-5090/abb744 ↗